A study from researchers at The Children’s Hospital of Philadelphia may add new lines to the textbook description of how cancer cells divide uncontrollably and develop into tumors.
Category Archive: University of Pennsylvania
Researchers at The Children’s Hospital of Philadelphia wanted to determine how common it is for clinicians to actually see food allergies occur in patients with eczema by performing a blood test during infancy.
Researchers at The Children’s Hospital of Philadelphia reported their latest results from their studies of an investigational personalized cell therapy for a highly aggressive form of cancer, acute lymphoblastic leukemia (ALL).
Some of the neurological and psychiatric complications associated with HIV may be side effects of the medications that control the virus, and not caused by the virus itself, according to a new study from researchers at The Children’s Hospital of Philadelphia and the University of Pennsylvania.
In the 10 years that the Center for Child Injury Prevention Studies (CChIPS) has been on the road to improving child safety, the unique collaboration between industry members, academia, and government has reached many milestones, which are being celebrated with a special anniversary report and timeline.
The LEGACY Girls Study, a study taking place across five sites in North America, is the first to focus on preadolescent girls growing up in families with breast cancer risk.
Funded by a $2.1 million award from the Patient-Centered Outcomes Research Institute, CHOP's James Guevara, MD, MPH, will study the comparative effectiveness of an electronic portal vis-à-vis in-person communication for ADHD.
The World Health Organization predicts pediatric traumatic brain injury (TBI) will become a major cause of death and disability of children within the next several years.
Researchers from The Children’s Hospital of Philadelphia have found a gender bias in the provision of treatment for idiopathic short stature with recombinant human growth hormone treatment.
An international collaboration of researchers has identified several progressive series of mutations that occur in tumor cells responsible for aggressive subsets of neuroblastoma that relapse after chemotherapy.